Full year revenue of $46.7 million, up from $13.5 million in the prior year, a 245% increase.
Net loss of $99.7 million is impacted by non-cash, non-recurring and extraordinary items, resulting in an Adjusted EBITDA1 loss of $10.4 million, a 5.1% increase over last year.
As of market close on June 28, 2024 Roadzen was included in the Russell 2000®, Russell 3000®, and Russell Microcap® indexes bringing new institutional shareholders.
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company”), a global leader in AI at the convergence of insurance and mobility, today announced its results for the twelve-months ended March 31, 2024.
"Roadzen had a remarkable year, achieving substantial revenue growth, maintaining our trajectory towards profitability, and significantly expanding our presence in the U.S. and U.K. markets, along with continued strong growth in India," commented Rohan Malhotra, CEO and Founder of Roadzen. "Our advanced technology group and AI research lab now support a robust global client base and infrastructure, including 101 large enterprise clients, such as leading insurers, automakers, and large fleets, in addition to approximately 3,200 small and medium businesses, including agents, brokers, dealerships, and smaller fleets. Looking ahead, we anticipate continued momentum and establishing Roadzen as a leader in vertical AI for auto insurance within the public markets, leveraging the strong foundation we've built over the past year."
Jean-Noël Gallardo, Roadzen’s CFO commented, “In preparation for 2024 year-end, we focused on simplifying and streamlining the organizational structure and internal financial reporting protocols to ready the Company for scale and another breakout year in 2025. We also focused on streamlining operations and eliminating redundancies. This allowed us to rationalize small subsidiaries that no longer align with our strategy, yielding a 7% reduction in headcount and the closure of under-performing assets.”
________________________
1Adjusted EBITDA is a non-GAAP financial metric. See “Non-GAAP Financial Measures” at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.
Fiscal Year Highlights
Revenue and Key Performance Indicators
Revenue reached $46.7 million, an increase of 245% over the prior year, due to the incremental revenue from U.S. and U.K. acquisitions, as well as continuing growth in India.
Revenue from brokerage solutions accounted for 65% of our revenue, increasing $21.3 million, or 232% over the prior year, while IaaS revenue accounted for the remaining 35% of revenue, increasing $11.8 million, or 270% over the prior year.
Gross margin continued to show improvement, with a slight increase over the prior year to 61.2% up from 60.1%.
As of March 31, 2024, we had 33 insurance customer agreements (including carriers, self-insureds and other entities processing insurance claims), compared to 26 in the prior year; 68 automotive customer agreements in fiscal 2024 compared to 23 in the prior year; and approximately 3,200 agents and fleet customer agreements in fiscal 2024 compared to approximately 2,000 in the prior year.
In the brokerage segment: 324,293 policies were sold during fiscal 2024 adding up to $61.8 million of Gross Written Premium (“GWP”), compared to 258,546 policies sold in the prior year for $38.0 million of GWP, a 25.5% and 62.6% increase respectively.
For the IaaS segment: 301,120 claims and vehicle inspections were conducted during the fiscal year compared to 220,781 the prior year, representing a 36.4% increase.
Expenses and Net Results
Operating expenses excluding Depreciation and Amortization totaled $104.1 million, an increase of $86.0 million compared to the prior year. This includes $61.2 million of non-cash expenses, comprised of $56.3 million of equity compensation expense related to RSUs granted to employees on September 18, 2023, and $4.9 million in provisions for doubtful accounts that include $2.8 million related to the issuance of preferred stock prior to the Business Combination (as defined in our SEC filings) and $2.1 million in advances made to de-consolidated subsidiaries.
Other expenses totaled $22.2 million, an increase of $19.5 million over the prior year, driven by $19.5 million of non-cash expense related to fair market valuation adjustments of financial instruments, including the Forward Purchase Agreement (“FPA”) and warrants.
In total, net loss for the fiscal year includes $89.4 million of non-cash, non-recurring and other extraordinary items that, when removed, result in an Adjusted EBITDA loss of $10.4 million compared to $9.9 million loss in the prior year. Adjusted EBITDA margin was -22.3% in fiscal 2024 compared to -73.1% in the prior year.
Balance Sheet
Cash on hand as of March 31, 2024 was $11.2 million compared to $0.6 million on March 31, 2023.
Current Assets were $49.8 million, primarily due to the $28.8 million FPA prepayment balance.
Current Liabilities totaled $65.7 million, including $17.4 million in Accounts Payable assumed by Roadzen in connection with the Business Combination, and $13.1 million for Mizuho Securities USA LLC (“Mizuho”) that includes short-term borrowings of $7.5 million and a $5.6 million fair valuation of warrants granted as part of the Mizuho debt agreement.
Long-Term Liabilities totaled $3.0 million, primarily made up of various debt instruments issued by the Company.
Russell Indexes
June 28, 2024 – Roadzen was added to the Russell Indexes, including the Russell 2000®, Russell 3000®, and Russell Microcap®, which will drive awareness from institutional shareholders and improve visibility as a publicly-listed company.
Roadzen Inc. |
Consolidated Balance Sheets |
(in US$, except per share data and share count) |
| | |
Particulars | | As of March 31,
2024 | As of March 31,
2023 |
Assets | | | |
Current assets: | | | |
Cash and cash equivalents | | 11,186,095 | | 589,340 | |
Accounts receivable, net | | 3,652,380 | | 1,535,985 | |
Inventories | | 70,667 | | 59,897 | |
Prepayments and other current assets | | 34,426,335 | | 3,181,936 | |
Investments | | 507,094 | | - | |
Total current assets | | 49,842,571 | | 5,367,158 | |
Restricted cash | | 378,993 | | 542,490 | |
Non marketable securities | | 1,514,796 | | 4,910,030 | |
Property and equipment, net | | 454,589 | | 232,493 | |
Goodwill | | 2,061,553 | | 996,441 | |
Operating lease right-of-use assets | | 822,327 | | 545,988 | |
Intangible assets, net | | 2,989,604 | | 2,469,158 | |
Other long-term assets | | 71,913 | | 117,484 | |
Total assets | | 58,136,346 | | 15,181,242 | |
| | | |
Liabilities, mezzanine equity and stockholders' deficit | | | |
Current liabilities | | | |
Current portion of long-term borrowings | | 2,228,471 | | 2,852,528 | |
Short-term borrowings | | 15,754,829 | | 4,875,801 | |
Due to insurer | | 8,918,849 | | — | |
Accounts payable and accrued expenses | | 29,573,638 | | 6,241,066 | |
Derivative warrant liabilities | | 5,585,955 | | — | |
Short-term operating lease liabilities | | 358,802 | | 208,697 | |
Other current liabilities | | 3,231,962 | | 2,503,893 | |
Total current liabilities | | 65,652,506 | | 16,681,985 | |
Long-term borrowings | | 1,472,933 | | 653,269 | |
Long-term operating lease liabilities | | 268,856 | | 360,306 | |
Other long-term liabilities | | 1,241,917 | | 294,301 | |
Total liabilities | | 68,636,212 | | 17,989,861 | |
| | | |
Commitments and contingencies (refer note 26) | | | |
| | | |
Mezzanine equity | | | |
None authorized or issued as of March 31, 2024; Series A and A1 preferred stock and additional paid in capital, $0.0001 par value per share, 81,635,738 shares authorized (Series A 5,442,383 and Series A1 76,193,356); 39,868,173 shares issued and outstanding as on March 31, 2023. | | — | | 48,274,279 | |
Shareholders' deficit | | | |
Preference shares, $0.0001 par value per share, 60,000,000 shares authorized and none issued as of March 31, 2024 and none authorized or issued as of March 31, 2023 | | — | | — | |
Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of March 31 2024 and $0.0001 par value per share, 108,840,000 shares authorized as of March 31, 2023; 68,440,829 shares and 16,501,984 shares issued and outstanding as of March 31, 2024 and March 31, 2023 respectively | | 84,974,378 | | 303,213 | |
Accumulated deficit | | (151,008,419 | ) | (51,448,299 | ) |
Accumulated other comprehensive income/(loss) | | (600,501 | ) | (66,903 | ) |
Other components of equity | | 56,560,706 | | 366,786 | |
Total shareholders’ deficit | | (10,073,836 | ) | (50,845,203 | ) |
Non-controlling interest | | (426,030 | ) | (237,695 | ) |
Total deficit | | (10,499,866 | ) | (51,082,898 | ) |
Total liabilities, Mezzanine equity and Shareholders’ deficit, Non-controlling interest | | 58,136,346 | | 15,181,242 | |
| | | |
| | | |
Roadzen Inc. |
Consolidated Statements of Operations |
(in US$, except per share data and share count) |
|
| | For the year ended
March 31, |
Particulars | | 2024 | | 2023 | |
Revenue | | 46,724,287 | | 13,560,498 | |
Costs and expenses: | | | |
Cost of services | | 18,132,757 | | 5,413,686 | |
Research and development | | 4,973,816 | | 2,670,333 | |
Sales and marketing | | 33,195,608 | | 10,736,173 | |
General and administrative | | 65,895,085 | | 4,648,242 | |
Depreciation and amortization | | 2,185,858 | | 1,624,208 | |
Total costs and expenses | | 124,383,124 | | 25,092,642 | |
Loss from operations | | (77,658,837 | ) | (11,532,144 | ) |
Interest income/(expense) | | (2,291,123 | ) | (776,023 | ) |
Fair value gains/(losses) in financial instruments carried at fair value | | (19,475,005 | ) | (1,009,374 | ) |
Gain on deconsolidation of subsidiaries | | 2,098,745 | | - | |
Impairment of goodwill and intangibles with definite life | | - | | (919,517 | ) |
Impairment of investment | | (3,395,234 | ) | - | |
Other income/(expense) net | | 838,728 | | (6,358 | ) |
Total other income/(expense) | | (22,223,889 | ) | (2,711,272 | ) |
(Loss)/Income before income tax expense | | (99,882,726 | ) | (14,243,416 | ) |
Less: income tax (benefit)/expense | | (23,648 | ) | (42,265 | ) |
Net (loss)/income before non-controlling interest | | (99,859,078 | ) | (14,201,151 | ) |
Net loss attributable to non-controlling interest, net of tax | | (189,743 | ) | (176,883 | ) |
Net (loss)/income attributable to Roadzen Inc. | | (99,669,335 | ) | (14,024,268 | ) |
| | | |
| | | |
Net (loss)/income attributable to Roadzen Inc. ordinary shareholders | | (99,669,335 | ) | (14,024,268 | ) |
Basic and diluted | | (2.26 | ) | (0.86 | ) |
| | | |
Weighted-average number of shares outstanding used to compute net loss per share attributable to Roadzen Inc. ordinary shareholders | | 44,032,410 | | 16,501,984 | |
| | | |
| | | | | |
Roadzen Inc. |
Consolidated Statements of Cash Flow |
(in US$) |
| | For the year ended
March 31, |
Particulars | | 2024 | | 2023 | |
| | | |
Cash flows from operating activities | | | |
Net loss including non controlling interest | | (99,859,078 | ) | (14,201,151 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | | | |
Depreciation and amortization | | 2,185,858 | | 1,624,208 | |
Stock based compensation | | 56,303,135 | | - | |
Deferred income taxes | | (86,020 | ) | (131,378 | ) |
Unrealised foreign exchange loss/(profit) | | (459,190 | ) | 9,184 | |
Fair value losses in financial instruments carried at fair value | | 19,475,005 | | 1,009,374 | |
Gain on deconsolidation of subsidiaries | | (2,098,745 | ) | - | |
Gain on fair valuation of investments | | (1,812 | ) | - | |
Impairment of investment | | 3,395,234 | | - | |
Gain on sale of property and equipment | | - | | (625 | ) |
Expected credit loss (net of reversal) | | 293,853 | | - | |
Provision on doubtful advances and receivables | | 4,877,222 | | - | |
Lease equalisation reserve | | - | | (9,675 | ) |
Impairment loss | | - | | 919,517 | |
Balances written off/(back) | | (51,513 | ) | 7,164 | |
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions: | | | |
Inventories | | (11,688 | ) | (9,352 | ) |
Income taxes, net | | (64,243 | ) | (55,766 | ) |
Accounts receivables, net | | 5,865,550 | | (943,470 | ) |
Prepayments and other assets | | (23,861,458 | ) | (529,692 | ) |
Accounts payable and accrued expenses and other current liabilities | | 19,344,448 | | 4,193,439 | |
Other liabilities | | (674,090 | ) | 571,519 | |
Net cash used in operating activities | | (15,427,532 | ) | (7,546,704 | ) |
| | | |
Cash flows from investing activities | | | |
Purchase of property and equipment, intangible assets and goodwill | | (455,924 | ) | (842,045 | ) |
Proceeds from sale of property, plant and equipment | | - | | 686 | |
Acquisition of businesses | | (5,749,200 | ) | - | |
Investment in mutual funds | | (500,000 | ) | - | |
Net cash used in investing activities | | (6,705,124 | ) | (841,359 | ) |
| | | |
Cash flows from financing activities | | | |
Proceeds from business combination | | 26,824 | | - | |
Proceeds from issue of preferred stock | | 6,079,409 | | 458,000 | |
Proceeds from exercise of preferred share warrants | | - | | 9,996 | |
Proceeds from long-term borrowings | | 2,438,014 | | 4,107,029 | |
Repayments of long-term borrowings | | (11,684 | ) | (612,645 | ) |
Net proceeds/(payments) from short-term borrowings | | 13,039,186 | | 4,398,343 | |
Net cash generated from financing activities | | 21,571,749 | | 8,360,723 | |
Effect of exchange rate changes on cash and cash equivalents | | (244,444 | ) | 72,752 | |
Net (decrease)/increase in cash and cash equivalents (including restricted cash) | | (805,351 | ) | 45,412 | |
Cash acquired in business combination | | 11,238,609 | | - | |
Cash and cash equivalents at the beginning of the period (including restricted cash) | | 1,131,830 | | 1,086,418 | |
Cash and cash equivalents at the end of the period (including restricted cash) | | 11,565,088 | | 1,131,830 | |
| | | |
Reconciliation of cash and cash equivalents | | | |
Cash and cash equivalents | | 11,186,095 | | 589,340 | |
Restricted cash | | 378,993 | | 542,490 | |
Total cash and cash equivalents | | 11,565,088 | | 1,131,830 | |
| | | |
Supplemental disclosure of cash flow information | | | |
Cash paid for interest, net of amounts capitalized | | 623,525 | | 457,177 | |
Cash paid for income taxes, net of refunds | | - | | 141,228 | |
Non-cash investing and financing activities | | | |
Exercise of warrant for issuance of convertible preferred stock | | - | | 103,159 | |
Convertible preferred stock issued on conversion of convertible notes | | - | | 24,006,892 | |
Consideration payable in connection with acquisitions | | 488,000 | | 243,036 | |
Interest accrued on borrowings | | 451,323 | | 257,188 | |
| | | |
The following table reconciles our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:
| For the year ended
March 31, |
Particulars | 2024 | | 2023 | |
Net loss | (99,859,078 | ) | (14,201,151 | ) |
Adjusted for: | | |
Other (income)/expense net | (838,728 | ) | 6,358 | |
Interest (income)/expense | 2,291,123 | | 776,023 | |
Fair value changes in financial instruments carried at fair value | 19,475,005 | | 1,009,374 | |
Gain on deconsolidation of subsidiaries | (2,098,745 | ) | - | |
Impairment of goodwill and intangibles with definite life | - | | 919,517 | |
Impairment of investment | 3,395,234 | | - | |
Tax (benefit)/expense | (23,648 | ) | (42,265 | ) |
Depreciation and amortization | 2,185,858 | | 1,624,208 | |
Stock based compensation expense | 56,303,135 | | - | |
Non-cash expenses | 1,048,353 | | - | |
Non-recurring expenses | 7,685,859 | | - | |
Adjusted EBITDA | (10,435,632 | ) | (9,907,936 | ) |
通年の収益は4,670万ドルで、前年の1,350万ドルから 245% 増加しました。
9,970万ドルの純損失は、非現金、非経常および特別項目の影響を受け、その結果、調整後EBITDA1損失は1,040万ドルで、昨年に比べて5.1％増加しました。
2024年6月28日の市場終了時点で、ロードゼンはラッセル2000®、ラッセル3000®、およびラッセルマイクロキャップ® インデックスに含まれており、新しい機関株主を獲得しています。
ニューヨーク、2024年7月1日（GLOBE NEWSWIRE）— 保険とモビリティの融合におけるAIのグローバルリーダーであるRoadzen Inc.（ナスダック：RDZN）（「Roadzen」または「当社」）は本日、2024年3月31日に終了した12か月間の業績を発表しました。
RoadzenのCEO兼創設者であるRohan Malhotraは、「Roadzenは目覚ましい年でした。大幅な収益成長を達成し、収益性への軌道を維持し、米国と英国の市場でのプレゼンスを大幅に拡大し、インドでも引き続き力強い成長を遂げました」とコメントしています。「当社の先端技術グループとAI研究所は現在、代理店、ブローカー、ディーラー、小規模車両を含む約3,200の中小企業に加えて、大手保険会社、自動車メーカー、大型車両などの101社の大企業顧客を含む、強固なグローバル顧客基盤とインフラストラクチャをサポートしています。将来を見据えて、この1年間に築き上げてきた強固な基盤を活用して、Roadzenが公開市場における自動車保険の垂直型AIのリーダーとしての地位を確立し、勢いが続くと予想しています。」
RoadzenのCFOであるJean-Noël Gallardoは次のようにコメントしています。「2024年末に備えて、2025年に向けて会社の規模拡大とブレイクアウトの年に備えるために、組織構造と内部財務報告プロトコルの簡素化と合理化に注力しました。また、業務の合理化と重複の排除にも注力しました。これにより、私たちの戦略に合致しなくなった小規模子会社を合理化することができ、人員を 7% 削減し、業績の悪い資産を閉鎖することができました。」
________________________
1調整後EBITDAは非GAAPベースの財務指標です。最も近いGAAP財務指標との調整など、詳細については、このプレスリリースの最後にある「非GAAP財務指標」を参照してください。
会計年度のハイライト
収益と主要業績評価指標
米国と英国の買収による収益の増加とインドの継続的な成長により、収益は4,670万ドルに達し、前年比245％増加しました。
仲介ソリューションからの収益は収益の65％を占め、2,130万ドル、前年比232％増加しました。一方、IaaSの収益は収益の残り35％を占め、売上高の残り35％を占め、前年比で1,180万ドル、つまり270％増加しました。
売上総利益率は引き続き改善を示し、前年比で 60.1% から 61.2% にわずかに増加しました。
2024年3月31日現在、当社は33件の保険顧客契約（運送業者、自己保険会社、その他の保険金請求を処理する事業体を含む）を前年同期は26件、2024年度には68件の自動車顧客契約、前年度の約2,000件に対し、2024年度には約3,200件の代理店および車両顧客契約を結んでいます。
証券セグメントでは、2024会計年度に324,293件の保険契約が売却され、合計で6,180万ドルの総保険料（「GWP」）となりました。前年に3,800万ドルのGWPで販売された保険契約は258,546件で、それぞれ25.5％と62.6％増加しました。
IaaSセグメントの場合：会計年度中に実施された請求および車両検査は、前年の220,781件と比較して301,120件で、36.4％増加しました。
経費と純成績
減価償却費を除く営業費用は合計1億410万ドルで、前年比8,600万ドル増加しました。これには、2023年9月18日に従業員に付与されたRSUに関連する5,630万ドルの株式報酬費用からなる6,120万ドルの非現金費用と、企業結合（当社のSEC提出書類で定義されている）前の優先株式の発行に関連する280万ドルと非連結子会社への210万ドルの前払い金を含む貸倒引当金490万ドルが含まれます。
その他の費用は合計2,220万ドルで、前年比1,950万ドル増加しました。これは、先物購入契約（「FPA」）やワラントを含む金融商品の公正市場評価調整に関連する1,950万ドルの非現金費用によるものです。
会計年度の純損失には、非現金、非経常およびその他の特別項目が合計8,940万ドル含まれます。これらを除くと、調整後EBITDA損失は、前年の990万ドルの損失に対し、1,040万ドルになります。2024会計年度の調整後EBITDAマージンは、前年度の-73.1％に対し、-22.3％でした。
貸借対照表
2024年3月31日現在の手元現金は、2023年3月31日時点の60万ドルに対し、1,120万ドルでした。
現在の資産は4,980万ドルでした。これは主に、FPAの前払い残高が2,880万ドルだったためです。
流動負債は合計6,570万ドルで、これには企業結合に関連してRoadzenが引き受けた買掛金1,740万ドルが含まれます。また、みずほ証券USALLC（「みずほ」）の流動負債は、750万ドルの短期借入とみずほ債務契約の一環として付与された560万ドルのワラントを含む1,310万ドルでした。
長期負債は合計300万ドルで、主に当社が発行したさまざまな債務証書で構成されていました。
ラッセル・インデックス
ロードゼン株式会社 |
連結貸借対照表 |
（米ドルで、1株あたりのデータと株式数を除く） |
| | |
細目 | | 3月31日の時点で、
2024 | 3月31日の時点で、
2023 |
資産 | | | |
流動資産： | | | |
現金および現金同等物 | | 11,186,095 | | 589,340 | |
売掛金、純額 | | 3,652,380 | | 1,535,985 | |
インベントリ | | 70,667 | | 59,897 | |
前払い金およびその他の流動資産 | | 34,426,335 | | 3,181,936 | |
投資 | | 507,094 | | - | |
流動資産合計 | | 49,842,571 | | 5,367,158 | |
制限付き現金 | | 378,993 | | 542,490 | |
市場性のない証券 | | 1,514,796 | | 4,910,030 | |
資産および設備、純額 | | 454,589 | | 232,493 | |
グッドウィル | | 2,061,553 | | 996,441 | |
オペレーティングリースの使用権資産 | | 822,327 | | 545,988 | |
無形資産、純額 | | 2,989,604 | | 2,469,158 | |
その他の長期資産 | | 71,913 | | 117,484 | |
総資産 | | 58,136,346 | | 15,181,242 | |
| | | |
負債、メザニンエクイティ、株主赤字 | | | |
現在の負債 | | | |
長期借入金の現在の部分 | | 2,228,471 | | 2,852,528 | |
短期借入 | | 15,754,829 | | 4,875,801 | |
保険会社のおかげで | | 8,918,849 | | — | |
買掛金と未払費用 | | 29,573,638 | | 6,241,066 | |
デリバティブワラント負債 | | 5,585,955 | | — | |
短期オペレーティングリース負債 | | 358,802 | | 208,697 | |
その他の流動負債 | | 3,231,962 | | 2,503,893 | |
流動負債合計 | | 65,652,506 | | 16,681,985 | |
長期借入金 | | 1,472,933 | | 653,269 | |
長期オペレーティングリース負債 | | 268,856 | | 360,306 | |
その他の長期負債 | | 1,241,917 | | 294,301 | |
負債総額 | | 68,636,212 | | 17,989,861 | |
| | | |
コミットメントと不測の事態（注記26を参照） | | | |
| | | |
メザニン・エクイティ | | | |
2024年3月31日現在、承認または発行されたものはありません。シリーズAおよびA1の優先株および追加払込資本、1株あたり額面0.0001ドル、承認済み株式81,635,738株（シリーズA 5,442,383およびシリーズA1 76,193,356）。2023年3月31日時点で発行済みおよび発行済株式39,868,173株。 | | — | | 48,274,279 | |
株主の赤字 | | | |
優先株式、1株あたり額面0.0001ドル、承認済み株式6,000,000株、2024年3月31日時点で発行済株式数は6,000株、2023年3月31日時点で承認または発行されたものはありません | | — | | — | |
普通株式と追加払込資本、1株あたり額面0.0001ドル、2024年3月31日現在の承認済み株式2億2000万株、1株あたり額面0.0001ドル、2023年3月31日現在の承認済み株式108,840,000株。2024年3月31日および2023年3月31日の時点でそれぞれ68,440,829株と16,501,984株が発行済み株式です | | 84,974,378 | | 303,213 | |
累積赤字 | | (151,008,419 | ) | (51,448,299) | ) |
その他の包括利益の累計/ (損失) | | (600,501) | ) | (66,903 | ) |
その他の資本の構成要素 | | 56,560,706 | | 366,786 | |
株主赤字総額 | | (10,073,836 | ) | (50,845,203 | ) |
非支配持分 | | (426,030 | ) | (237,695) | ) |
赤字合計 | | (10,499,866,866 | ) | (51,082,898 | ) |
負債総額、メザニンエクイティ、株主赤字、非支配持分 | | 58,136,346 | | 15,181,242 | |
| | | |
| | | |
ロードゼン株式会社 |
連結営業報告書 |
（米ドルで、1株あたりのデータと株式数を除く） |
|
| | 終了した年度について
3月31日、 |
細目 | | 2024 | | 2023 | |
収入 | | 46,724,287 | | 13,560,498 | |
費用と経費: | | | |
サービスコスト | | 18,132,757 | | 5,413,686 | |
研究開発 | | 4,973,816 | | 2,670,333 | |
セールスとマーケティング | | 33,195,608 | | 10,736,173% | |
一般と管理 | | 65,895,085 | | 4,648,242 | |
減価償却と償却 | | 2,185,858 | | 1,624,208 | |
費用と経費の合計 | | 124,383,124 | | 25,092,642 | |
事業による損失 | | (77,658,837) | ) | (11,532,144 | ) |
利息収入/（費用） | | (2,291,123 | ) | (776,023) | ) |
公正価値で保有される金融商品の公正価値利益/（損失） | | (19,475,005) | ) | (1,009,374 | ) |
子会社の連結解除による利益 | | 2,098,745 | | - | |
のれんや期限のある無形資産の減損 | | - | | (919,517です | ) |
投資の減損 | | (3,395,234) | ) | - | |
その他の収入/（費用）純額 | | 838,728 | | (6,358) | ) |
その他の収入の合計/ (費用) | | (22,223,889) | ) | (2,711,272 | ) |
(損失) /所得税費用控除前利益 | | (99,882,726) | ) | (14,243,416 | ) |
控除：所得税（給付）/経費 | | (23,648 | ) | (42,265) | ) |
非支配持分控除前の純利益（損失）/収益 | | (99,859,078 | ) | (14,201,151 | ) |
非支配持分に帰属する純損失、税引後 | | (189,743 | ) | (176,883) | ) |
Roadzen社に帰属する純利益（損失）/利益 | | (99,669,335) | ) | (14,024,268 | ) |
| | | |
| | | |
Roadzen Inc. の普通株主に帰属する純利益（損失）/利益 | | (99,669,335) | ) | (14,024,268 | ) |
ベーシックと希釈 | | (2.26 | ) | (0.86 | ) |
| | | |
Roadzen Inc. の普通株主に帰属する1株当たりの純損失の計算に使用される加重平均発行済株式数 | | 44,032,410 | | 16,501,984 | |
| | | |
| | | | | |
ロードゼン株式会社 |
連結キャッシュフロー計算書 |
(米ドルで) |
| | 終了した年度について
3月31日、 |
細目 | | 2024 | | 2023 | |
| | | |
営業活動によるキャッシュフロー | | | |
非支配持分を含む純損失 | | (99,859,078 | ) | (14,201,151 | ) |
純損失を営業活動に使用された純現金と調整するための調整： | | | |
減価償却と償却 | | 2,185,858 | | 1,624,208 | |
株式ベースの報酬 | | 56,303,135 | | - | |
繰延所得税 | | (86,020) | ) | (131,378) | ) |
未実現為替差損/（利益） | | (459,190 | ) | 9,184 | |
公正価値で保有される金融商品の公正価値損失 | | 19,475,005 | | 1,009,374 | |
子会社の連結解除による利益 | | (2,098,745 | ) | - | |
投資の公正評価による利益 | | (1,812) | ) | - | |
投資の減損 | | 3,395,234 | | - | |
不動産および設備の売却益 | | - | | (625) | ) |
予想信用損失（逆転を差し引いたもの） | | 293,853 | | - | |
貸倒引当金と売掛金に関する引当金 | | 4,877,222 | | - | |
リース・イコライゼーション・リザーブ | | - | | (9,675) | ) |
減損損失 | | - | | 919,517です | |
残高の償却/（裏面） | | (51,513) | ) | 7,164 | |
取得した資産と買収から引き受けた負債を差し引いた資産と負債の変動： | | | |
インベントリ | | (11,688) | ) | (9,352 | ) |
所得税、純額 | | (64,243 | ) | (55,766%) | ) |
売掛金、純額 | | 5,865,550 | | (943,470さん) | ) |
前払い金およびその他の資産 | | (23,861,458 | ) | (529,692 | ) |
買掛金、未払費用、その他の流動負債 | | 19,344,448 | | 4,193,439 | |
その他の負債 | | (674,090 | ) | 571,519 | |
営業活動に使用された純現金 | | (15,427,532 | ) | (7,546,704 | ) |
| | | |
投資活動によるキャッシュフロー | | | |
資産と設備、無形資産とのれんの購入 | | (455,924 | ) | (842,045) | ) |
不動産、プラント、設備の売却による収入 | | - | | 686 | |
事業の買収 | | (5,749,200 | ) | - | |
投資信託への投資 | | (50万件) | ) | - | |
投資活動に使用された純現金 | | (6,705,124 | ) | (841,359) | ) |
| | | |
財務活動によるキャッシュフロー | | | |
企業結合による収入 | | 26,824 | | - | |
優先株式の発行による収入 | | 6,079,409です | | 458,000です | |
優先新株予約権の行使による収入 | | - | | 9,996 | |
長期借入による収入 | | 2,438,014 | | 4,107,029 | |
長期借入金の返済 | | (11,684) | ) | (612,645 | ) |
短期借入による純収入/（支払い） | | 13,039,186 | | 4,398,343 | |
財務活動から生み出される純現金 | | 21,571,749 | | 8,360,723 | |
現金および現金同等物に対する為替レートの変動の影響 | | (244,444 | ) | 72,752 | |
現金および現金同等物（制限付現金を含む）の純額（減少）/増加 | | (805,351 | ) | 45,412 | |
企業結合で獲得した現金 | | 11,238,609 | | - | |
期初の現金および現金同等物（制限付現金を含む） | | 1,131,830 | | 1,086,418 | |
期末の現金および現金同等物（制限付現金を含む） | | 11,565,088 | | 1,131,830 | |
| | | |
現金と現金同等物の調整 | | | |
現金および現金同等物 | | 11,186,095 | | 589,340 | |
制限付き現金 | | 378,993 | | 542,490 | |
現金および現金同等物の合計 | | 11,565,088 | | 1,131,830 | |
| | | |
キャッシュフロー情報の補足開示 | | | |
利息として支払われた現金、資本化された金額を差し引いたもの | | 623,525 | | 457,177 | |
所得税として支払われた現金、払い戻しを差し引いたもの | | - | | 141,228 | |
非現金投資と資金調達活動 | | | |
転換優先株式の発行に関するワラントの行使 | | - | | 103,159 | |
転換社債の転換時に発行される転換優先株式 | | - | | 24,006,892 | |
買収に関連して支払うべき対価 | | 488,000 | | 243,036 | |
借入により発生した利息 | | 451,323 | | 257,188 | |
| | | |
次の表は、米国会計基準に従って報告された当社の純損失と調整後EBITDAを照合したものです。
| 終了した年度について
3月31日、 |
細目 | 2024 | | 2023 | |
純損失 | (99,859,078 | ) | (14,201,151 | ) |
調整対象: | | |
その他（収入）/経費（純額） | (838,728) | ) | 6,358 | |
利息（収入）/費用 | 2,291,123 | | 776,023 | |
公正価値で保有される金融商品の公正価値変動 | 19,475,005 | | 1,009,374 | |
子会社の連結解除による利益 | (2,098,745 | ) | - | |
のれんや期限のある無形資産の減損 | - | | 919,517です | |
投資の減損 | 3,395,234 | | - | |
税金（給付）/経費 | (23,648 | ) | (42,265) | ) |
減価償却と償却 | 2,185,858 | | 1,624,208 | |
株式ベースの報酬費用 | 56,303,135 | | - | |
現金以外の費用 | 1,048,353 | | - | |
非経常経費 | 7,685,859 | | - | |
調整後EBITDA | (10,435,632 | ) | (9,907,936 | ) |
